Tidal Investments’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.63M Sell
75,790
-755
-1% -$32.4K 0.01% 1085
2026
Q1
$2.81M Buy
76,545
+50,958
+199% +$2.41M 0.01% 1026
2025
Q4
$1.3M Sell
25,587
-29,227
-53% -$1.49M ﹤0.01% 1140
2025
Q3
$3.04M Buy
54,814
+35,467
+183% +$2.08M 0.01% 741
2025
Q2
$1.34M Buy
19,347
+3,419
+21% +$233K 0.01% 900
2025
Q1
$1.11M Sell
15,928
-68,739
-81% -$5.68M 0.01% 939
2024
Q4
$7.28M Buy
84,667
+77,364
+1,059% +$8.37M 0.06% 334
2024
Q3
$870K Sell
7,303
-2,315
-24% -$309K 0.01% 1069
2024
Q2
$1.37M Buy
9,618
+5,472
+132% +$725K 0.02% 732
2024
Q1
$532K Buy
4,146
+481
+13% +$57.3K 0.01% 1166
2023
Q4
$379K Buy
+3,665
New +$362K 0.01% 1066

Other funds holding NVO

Tidal Investments's NVO Position: Q2 2026 in Review

Tidal Investments reduced its Novo Nordisk (NVO) stake by 0.99% in Q2 2026, selling an estimated $32.4K and leaving 75,790 shares worth $3.63M. The position accounts for 0.01% of the portfolio, ranked #1085.

Tidal Investments first reported a position in NVO in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.28M in Q4 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Tidal Investments held 75,790 shares of Novo Nordisk worth $3.63M as of Q2 2026.
  • Tidal Investments sold 755 Novo Nordisk shares in Q2 2026, an estimated $32.4K.
  • Novo Nordisk made up 0.01% of Tidal Investments's portfolio in Q2 2026, its #1085 holding.
  • Tidal Investments first reported a position in Novo Nordisk in Q4 2023 and has held it in 11 quarters since.
  • Tidal Investments's Novo Nordisk position peaked at $7.28M in Q4 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.